Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
GSK advances dual-antigen mRNA flu vaccine to Phase III after positive Phase II
1+ week, 4+ day ago (398+ words) AllSci Positive Phase II data for GSK's mRNA seasonal influenza vaccine candidate FLUm3HA.b-3NA have cleared the bar for a Phase III efficacy trial, with the UK giant reporting higher immune responses against all tested influenza strains compared to both standard-dose and…...
GSK's mRNA Flu Vaccine Heads to Phase III
1+ week, 4+ day ago (370+ words) A new generation of influenza vaccines may be taking shape. GSK announced on Sept. 1, 2026, that it will advance its investigational mRNA seasonal flu vaccine candidate into a pivotal Phase III trial following positive Phase II results presented at the OPTIONS…...
Will Blodgett on Aging With Dignity: How Tredway Is Reimagining Affordable Senior Housing
1+ week, 4+ day ago (255+ words) Wednesday, 2 September 2026 Walk-in showers, dimmable lighting, community rooms with meal programs, and a growing set of health partnerships: inside how a preservation platform is redesigning senior affordable housing around the needs of residents. At many of Tredway’s senior affordable communities,…...
‘A Slippery Slope’: Case-Mix Creep, Expanded MDS Reporting Could Dampen SNF Payment Gains
1+ week, 5+ day ago (971+ words) Pexels | CC BY-SA 2.0 All this means more meticulous documentation and coding compliance if providers want to protect their modest reimbursement increase. Facilities should determine how many additional assessments they will need to complete, evaluate whether current staff can handle the…...
GSK???s Pivotal Test for mRNA Flu Vaccine Aims to Show Two Targets Are Better Than One
1+ week, 5+ day ago (465+ words) GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of the virus. That could be an advantage over Moderna’s recently approved mRNA flu shot, which addresses just one of…...
Rebate cut puts cataract benefits under scrutiny
1+ week, 5+ day ago (539+ words) Insurance Business Rebate cut puts cataract benefits under scrutiny Private Healthcare Australia submission ties eye-care access directly to affordability of cover A proposal to strip Australians aged 65 and over of their higher private health insurance rebate is drawing new attention…...
GSK to advance mRNA flu vaccine to late-stage trial
1+ week, 6+ day ago (91+ words) Sept 1 (Reuters) - GSK said on Tuesday it will advance its mRNA-based seasonal influenza vaccine candidate into a late-stage trial after mid-stage data showed it generated stronger immune responses than currently approved standard- and h... GSK to advance mRNA flu vaccine…...
Senior Center Expansion Planned In Hillsborough
1+ week, 6+ day ago (242+ words) HILLSBOROUGH, NJ — A "bigger, better, awesome" senior center is being planned in Hillsborough, Mayor Catherine Payne shared. At the Aug. 25 Committee meeting, Payne said Somerset County purchased 2.5 acres next to the area of the existing senior center in Hillsborough at…...
Nursing home residents roll through 'sprinkler car wash' to beat the summer heat | Fox News Video
2+ week, 15+ hour ago (58+ words) Nursing home residents roll through 'sprinkler car wash' to beat the summer heat Fox News Nursing home residents roll through 'sprinkler car wash' to beat the summer heat Nursing home residents in Manchester, New Hampshire, get their own twist on…...
mRNA vaccine to mount more potent defense against the flu
2+ week, 20+ hour ago (595+ words) With another flu season fast approaching, the medical community has been abuzz with the news that the Food and Drug Administration's recently approved Moderna's mRNA influenza vaccine for older adults — pending an additional trial in the targeted age groups: 50-65 and…...